Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?

Diabetes Mellitus (DM) is amongst the most notable causes of years of life lost worldwide and its prevalence increases perpetually. The disease is characterized as multisystemic dysfunctions attributed to hyperglycemia resulting directly from insulin resistance (IR), inadequate insulin secretion, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolosowicz, Marta, Prokopiuk, Slawomir, Kaminski, Tomasz W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029454/
https://www.ncbi.nlm.nih.gov/pubmed/35454311
http://dx.doi.org/10.3390/medicina58040472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029454/
https://www.ncbi.nlm.nih.gov/pubmed/35454311
http://dx.doi.org/10.3390/medicina58040472

Ejemplares similares